AbL Diagnostics SA
F:9BK0
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
AbL Diagnostics SA
F:9BK0
|
FR |
|
First Bancshares Inc (Mississippi)
F:3RY
|
US |
|
Compass Gold Corp
OTC:COGDF
|
CA |
|
F
|
FendX Technologies Inc
OTC:FDXTF
|
CA |
|
M
|
Morarjee Textiles Ltd
BSE:532621
|
IN |
|
Caltagirone SpA
F:QCG
|
IT |
|
F
|
FE Battery Metals Corp
OTC:LINMF
|
CA |
|
C
|
Civmec Ltd
F:1CV
|
AU |
|
C
|
Caltagirone SpA
SWB:QCG
|
IT |
|
Caltagirone SpA
LSE:0OIY
|
IT |
Wall St Price Targets
9BK0 Price Targets Summary
AbL Diagnostics SA
According to Wall Street analysts, the average 1-year price target for 9BK0 is 7.75 EUR with a low forecast of 7.67 EUR and a high forecast of 7.97 EUR.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is 9BK0's stock price target?
Price Target
7.75
EUR
According to Wall Street analysts, the average 1-year price target for 9BK0 is 7.75 EUR with a low forecast of 7.67 EUR and a high forecast of 7.97 EUR.
What is the Revenue forecast for AbL Diagnostics SA?
Projected CAGR
59%
Over the last 8 years, the compound annual growth rate for Revenue has been 34%. The projected CAGR for the next 3 years is 59%.
What is the Operating Income forecast for AbL Diagnostics SA?
Projected CAGR
199%
Over the last 8 years, the compound annual growth rate for Operating Income has been 6%. The projected CAGR for the next 3 years is 199%.
What is the Net Income forecast for AbL Diagnostics SA?
Projected CAGR
39%
The compound annual growth rate for Net Income over the next 2 years is 39%.
